Table 1.

Socio-demographic and clinical characteristics of enrolled participants who completed the study. Infant birth weight was only available for health facility births (n=21). Plan B+ refers to the WHO policy that all HIV-positive, pregnant women should receive ART. The regimen is tenofovir (TDF), lamivudine (3TC), and efavirenz (EFV). Additional abbreviation: nucleoside reverse transcriptase inhibitor (NRTI).

	Total, No. (%)
Antenatal maternal ART regimen (n=22)
Plan B+ (TDF/3TC/EFV)	18 (82%)
ART, first line other than Plan B+ (2NRTI + EFV)	1 (5%)
ART, second line (2 NRTI + PI)	3 (14%)
Estimated gestational age at enrollment (n=22)
23 – 32 weeks	10 (45%)
33 – 36 weeks	77 (32%)
37+ weeks	4 (18%)
Unknown	1 (5%)
Infant Gender (n=22)
Male	10 (45%)
Female	12 (55%)
Estimated gestational age at birth (n=22)
35– 36 weeks	3(13%)
37 – 40 weeks	7 (32%)
41+ weeks	7 (32%)
Unknown	5 (23%)
Birth weight (average: 2.9kg +/−0.5kg, n=21; n=1 home delivery)
2.0–2.4kg	4 (19%)
2.5 – 2.9kg	9 (43%)
3.0 – 3.4kg	5 (24%)
3.5 – 4.0kg	3 (14%)
Follow-up weight, average NVP level (average: 2.9kg +/− 0.6kg, n=22)
2.0 – 2.4kg, 7,500ng/ml	5 (23%)
2.5 – 2.9kg, 6,500ng/ml	6 (27%)
3.0 – 4.0kg, 2,600ng/ml	11 (50%)